Doctor debunks 6 common cervical cancer myths that put women at risk. Learn why early screening, vaccination, and awareness ...

The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study (NCT06385080).

The IMMUNEBOOST-HPV trial investigated whether adding nivolumab (Opdivo) immunotherapy before standard chemoradiation could improve outcomes for patients with high-risk oropharyngeal cancer. Although ...

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.

The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for subcutaneous Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as a monotherapy for adults with advanced ...

You can reduce your risk of developing bowel cancer just by adopting a healthier lifestyle. Some helpful changes you can make are: So no matter how old you are, small actions including screening ...

Government, private sector, and healthcare leaders gathered to pursue a whole-of-society approach and chart actions from screening to survivorship at ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced a major, peer-reviewed publication demonstrating the power of ...

Why do only some patients with autoimmune hyperthyroidism develop thyroid eye disease?

Athena Porter, an Iowa mother, shares her experience with cervical cancer caused by HPV, highlighting the importance of vaccination to prevent the disease.

Nadia Surry February is National Minority Health Month — a time to bring attention to a disease that should no longer be taking lives, yet continues to do so, especially those of Black women in Black ...